# EDGAR Filing Document

**Accession Number:** 0001205922
**File Stem:** 0000000000-23-000897
**Filing Date:** 2023-1
**Character Count:** 3292
**Document Hash:** f325b09e8e8ffb0c7c7ed512e60b88af
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-23-000897.hdr.sgml**: 20230301

**ACCESSION NUMBER**: 0000000000-23-000897

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230126

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** VACCINEX, INC.
- **CENTRAL INDEX KEY:** 0001205922
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 161603202
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD

**BUSINESS ADDRESS:**
- **STREET 1:** 1895 MOUNT HOPE AVE
- **CITY:** ROCHESTER
- **STATE:** NY
- **ZIP:** 14620
- **BUSINESS PHONE:** 585-271-2700

**MAIL ADDRESS:**
- **STREET 1:** 1895 MOUNT HOPE AVE
- **CITY:** ROCHESTER
- **STATE:** NY
- **ZIP:** 14620

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** VACCINEX INC
- **DATE OF NAME CHANGE:** 20021114

## Text-Extract

```

United States securities and exchange commission logo

                          January 26, 2023

       Maurice Zauderer, Ph.D.
       President and Chief Executive Officer
       Vaccinex, Inc.
       1895 Mount Hope Avenue
       Rochester, NY

                                                        Re: Vaccinex, Inc.
                                                            Registration
Statement on Form S-3
                                                            Filed January 24,
2023
                                                            File No. 333-269385

       Dear Maurice Zauderer:

              This is to advise you that we have not reviewed and will not
review your registration
       statement.

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

                                                        Please contact Tyler
Howes at 202-551-3370 with any questions.

                          Sincerely,

                          Division of Corporation Finance

                          Office of Life Sciences
       cc:                                              William Intner, Esq.

```

### Attached PDF Documents

**Attachment 1:** `filename1`

![img-0.jpeg](img-0.jpeg)

DIVISION OF
CORPORATION FINANCE

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

January 26, 2023

Maurice Zauderer, Ph.D.
President and Chief Executive Officer
Vaccinex, Inc.
1895 Mount Hope Avenue
Rochester, NY

**Re: Vaccinex, Inc.**
**Registration Statement on Form S-3**
**Filed January 24, 2023**
**File No. 333-269385**

Dear Maurice Zauderer:

This is to advise you that we have not reviewed and will not review your registration statement.

Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please contact Tyler Howes at 202-551-3370 with any questions.

Sincerely,

Division of Corporation Finance
Office of Life Sciences

cc: William Intner, Esq.